On Sep 28, 2021 Kytopen closed a Series A round and raised $30,000,000 from Alexandria Venture Investments, Horizon Ventures, John Ballantyne, MassVentures, Michael Chambers, Northpond […]
Series B – SmartLabs
On Sep 20, 2021 SmartLabs closed a Series B round and raised $250,000,000 from ArrowMark Partners, Breed’s Hill Capital, Conversion Ventures LLC, Onex Falcon, Winslow […]
Grant – Pegasus Biotech
On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Grant – Pegasus Biotech
On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Avitide acquired by Repligen
Sep 16, 2021 Repligen has entered into an agreement to acquire Avitide in a $150,000,000 deal. Repligen based at Waltham, Massachusetts, United States. “Repligen: Inspiring […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Series A – Walking Fish Therapeutics
On Sep 13, 2021 Walking Fish Therapeutics closed a Series A round and raised $50,000,000 from Emerson Collective, Illumina Ventures, Quan Capital, featuring lead investors […]
